Laboratory Reference Grade Compounds

CagriSema (10mg Dual Incretin Blend)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱4,180.00
Out of stock
Net Content10MG
InclusionAnalytical Lab Set
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose0.5 mg – 2.4 mg Weekly SubQSyringe: 10.0 units (0.10 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
CagriSema (10mg Dual Incretin Blend)10MG · Analytical Lab Set
₱4,180.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: CagriSema is an advanced dual-hormone combination peptide pairing Cagrilintide (a long-acting amylin analogue) and Semaglutide (a validated GLP-1 receptor agonist) in a precise 1:1 stoichiometric ratio (5mg / 5mg).

How it works: By concurrently engaging the area postrema and ventral tegmental area via calcitonin/RAMP amylin receptor complexes while stimulating hypothalamic GLP-1 receptors, CagriSema produces profound synergistic suppression of appetite, deceleration of gastric emptying, and restoration of glycemic setpoints exceeding either agent alone.

Why researchers study it: Investigated in Phase 3 trials (REDEFINE program) for unmatched weight reduction (exceeding 25% in clinical cohorts) and significant improvements in cardiovascular and metabolic biomarkers.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryMetabolic Signaling & Incretins
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry NumberBlend (Cagrilintide 1415456-99-3 / Semaglutide 910463-68-2)
PubChem CID56843331↗
Purity Specification≥99.0% (HPLC-grade dual component)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaCagrilintide (C183H286N48O57) + Semaglutide (C187H291N45O59)
🧬 Formulation Clarification · Single-Vial Blend

All-in-One Pre-Mixed Peptide Formulation

This product is a Blend (1 physical vial) where active peptide compounds are co-lyophilized into a single cake for simplified reconstitution. If your research requires staggered administration windows (e.g. Fasted AM vs Pre-Bed PM) or custom stoichiometric titrations, you can stack separate vials in our Stacking Studio.

Open Stacking Studio